These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19. Chien M; Anderson TK; Jockusch S; Tao C; Li X; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J J Proteome Res; 2020 Nov; 19(11):4690-4697. PubMed ID: 32692185 [TBL] [Abstract][Full Text] [Related]
25. Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation. Kato K; Honma T; Fukuzawa K J Mol Graph Model; 2020 Nov; 100():107695. PubMed ID: 32702590 [TBL] [Abstract][Full Text] [Related]
26. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery. Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307 [TBL] [Abstract][Full Text] [Related]
27. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965 [TBL] [Abstract][Full Text] [Related]
28. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Jiang Y; Yin W; Xu HE Biochem Biophys Res Commun; 2021 Jan; 538():47-53. PubMed ID: 32943188 [TBL] [Abstract][Full Text] [Related]
29. BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Tang W-F; Chang Y-H; Lin C-C; Jheng J-R; Hsieh C-F; Chin Y-F; Chang T-Y; Lee J-C; Liang P-H; Lin C-Y; Lin G-H; Cai J-Y; Chen Y-L; Chen Y-S; Tsai S-K; Liu P-C; Yang C-M; Shadbahr T; Tang J; Hsu Y-L; Huang C-H; Wang L-Y; Chen CC; Kau J-H; Hung Y-J; Lee H-Y; Wang W-C; Tsai H-P; Horng J-T Antimicrob Agents Chemother; 2024 Apr; 68(4):e0095623. PubMed ID: 38446062 [TBL] [Abstract][Full Text] [Related]
30. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278 [TBL] [Abstract][Full Text] [Related]
31. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models. Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274 [TBL] [Abstract][Full Text] [Related]
32. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir. Banerjee A; Kanwar M; Maiti S Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419 [TBL] [Abstract][Full Text] [Related]
33. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323 [TBL] [Abstract][Full Text] [Related]
34. Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex. Wu J; Wang H; Liu Q; Li R; Gao Y; Fang X; Zhong Y; Wang M; Wang Q; Rao Z; Gong P Cell Rep; 2021 Oct; 37(4):109882. PubMed ID: 34653416 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 RNA polymerase as target for antiviral therapy. Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758 [TBL] [Abstract][Full Text] [Related]
36. Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir. Gordon CJ; Lee HW; Tchesnokov EP; Perry JK; Feng JY; Bilello JP; Porter DP; Götte M J Biol Chem; 2022 Feb; 298(2):101529. PubMed ID: 34953856 [TBL] [Abstract][Full Text] [Related]
37. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Zhai Y; Sun F; Li X; Pang H; Xu X; Bartlam M; Rao Z Nat Struct Mol Biol; 2005 Nov; 12(11):980-6. PubMed ID: 16228002 [TBL] [Abstract][Full Text] [Related]
38. Development of a Simple Lu G; Zhang X; Zheng W; Sun J; Hua L; Xu L; Chu XJ; Ding S; Xiong W Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122171 [TBL] [Abstract][Full Text] [Related]